MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Objective Characteristics and Brain Network Alterations in Early-Stage Parkinson’s Disease with Gastric Motility Disorder

    J-Y. Jin, X-Y. Cheng, C-J. Mao, C-F. Liu (Suzhou, China)

    Objective: To characterize objective gastric motility disorder (GMD) in early-stage Parkinson’s disease (PD) and explore the underlying central neural network and structural alterations using multimodal…
  • 2026 International Congress

    Pelvic periosteal stimulation for Axial Rigidity in Parkinson’s Disease: A Retrospective Case Series

    A. Ahn, C. Peterson, K. Ahn (Pocheon-si, Republic of Korea)

    Objective: To describe clinical changes following pelvic periosteal stimulation in patients with Parkinson’s disease (PD) and axial symptoms. Background: Axial symptoms in PD, including postural…
  • 2026 International Congress

    Long-term evolution of deep brain stimulation parameters in Parkinson´s Disease: A 6-year analysis.

    D. Oropeza-Velázquez, A. Morales-Velez, LA. Haro-Santillan, M. Velázquez-Vaquero, D. Oropeza-Canto, E. Peña-Andrade, Y. Tiburcio-Núñez, D. Blumenkron-Marroquín, A. Romero-Pérez, CE. Chávez-Donis (Puebla, Mexico)

    Objective: Characterize longitudinal evolution of Deep Brain Stimulation (DBS) parameters in patients with Parkinson´s Disease (PD) over a 6-year period and evaluate stability of programming…
  • 2026 International Congress

    Allogeneic iPSC-Derived Dopaminergic Progenitor Transplantation for Parkinson’s Disease: A Phase 1, Dose-Escalation Trial

    D. Su, X. Wang, J. Zhang, X. Zheng, J. Luo, Z. Wang, L. Ma, J. Xi, P. Yan, X. Li, F. Meng, T. Feng (Beijing, China)

    Objective: To evaluate the safety, tolerability, and preliminary efficacy of putaminal implantation of XS411 (allogeneic iPSC-derived dopaminergic progenitors) in advanced PD  (NCT07080775). Background: Parkinson’s disease (PD)…
  • 2026 International Congress

    Thalamic Hub Dysregulation in FCMTE1: Multimodal MRI and Gene-Imaging Evidence

    JX. Li, HT. Wang, B. Wang, W. Luo (Hangzhou, China)

    Objective: To characterize brain network abnormalities and gene-imaging associations in genetically confirmed FCMTE1 (SAMD12) patients using multimodal MRI. Background: Familial cortical myoclonic tremor with epilepsy…
  • 2026 International Congress

    Efficacy of Deutetrabenazine in Patients with Tourette Syndrome: A Meta-Analysis of Randomized Controlled Trials

    M. Zanaty, H. Sabet (Qena, Egypt)

    Objective: To evaluate the efficacy of deutetrabenazine in patients with Tourette syndrome (TS). Background: Deutetrabenazine is a selective vesicular monoamine transporter 2 (VMAT2) inhibitor. While…
  • 2026 International Congress

    Wearable Sensors Identify Mobility Features Associated With Parkinson’s Disease Years Before Clinical Diagnosis

    N. Levanon, A. Thaler, JM. Hausdorff, N. Gur, A. Mirelman (Tel Aviv, Israel)

    Objective: To evaluate longitudinal prospective progression from gait and mobility data from individuals who were later diagnosed with PD. Background: Diagnosis of clinical Parkinson's disease…
  • 2026 International Congress

    Low-Intensity Treadmill Training Preserves Motor Function and Muscle Mass Through Mitochondrial and Antioxidant Regulation in a Rat Model of Parkinson’s Disease

    TH. Yeh, CC. Chiu, HY. Huang (Taipei City, Taiwan)

    Objective: To identify an exercise regimen with the greatest neuroprotective benefit in Parkinson’s disease (PD) and determine whether low-intensity treadmill training preserves motor function and…
  • 2026 International Congress

    A Rare Case of PLA2G6 Gene Related Early-Onset Dystonia-Parkinsonism; What Not to Miss Clinically and Radiologically

    Y. Degirmenci (Istanbul, Turkey)

    Objective: PLA2G6-associated neurodegeneration (PLAN) is a rare form of neurodegeneration with brain iron accumulation (NBIA) leading to heterogeneous clinical manifestation including infantile neuroaxonal dystrophy, atypical…
  • 2026 International Congress

    Prevalence of drooling in Parkinson’s disease: a multi-center observational study

    M. Iijima, R. Morimoto, K. Suzuki, T. Osada, S. Nogawa, Y. Okuma (Tokyo, Japan)

    Objective: This study investigated the prevalence of drooling and related factors. Background: The prevalence of drooling in Parkinson's disease (PD) varies widely, from 10% to…
  • « Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley